Search Results - Mitchell S. Cairo

Refine Results
  1. 1

    <i>TP53</i> binding domain mutations are bad news in Burkitt lymphoma by Mitchell S. Cairo

    Published in Haematologica (2024-04-01)
    Get full text
    Article


  2. 2

    A humanized orthotopic mouse model for preclinical evaluation of immunotherapy in Ewing sarcoma by Wen Luo, Wen Luo, Hai Hoang, Yanling Liao, Jian Pan, Janet Ayello, Mitchell S. Cairo, Mitchell S. Cairo, Mitchell S. Cairo, Mitchell S. Cairo

    Published in Frontiers in Immunology (2023-10-01)
    Get full text
    Article


  3. 3

    Tumor lysis syndrome: current perspective by Jessica Hochberg, Mitchell S. Cairo

    Published in Haematologica (2008-01-01)
    Get full text
    Article


  4. 4

    CAR-NK’s balancing act: when scFv affinity is not too tight, not too loose… but just right? by Mitchell S Cairo, Yanling Liao

    Published in Journal for ImmunoTherapy of Cancer (2025-05-01)
    Get full text
    Article


  5. 5

    Persistent Epstein-Barr virus viremia in NK-/T-cell lymphoma: bad boys for life! by Ana C. Xavier, Yanling Liao, Mitchell S. Cairo

    Published in Haematologica (2025-06-01)
    Get full text
    Article


  6. 6

    Reading through the nonsense: Gentamicin and ELX-02 as rescuing therapies for epidermolysis bullosa by Morgan Anderson-Crannage, Mitchell S. Cairo, Yanling Liao

    Published in Molecular Therapy: Nucleic Acids (2024-12-01)
    Get full text
    Article


  7. 7

    Inflammation-mediated fibroblast activation and immune dysregulation in collagen VII-deficient skin by Morgan Anderson-Crannage, Morgan Anderson-Crannage, Alex M. Ascensión, Olga Ibanez-Solé, Hongwen Zhu, Edo Schaefer, Darcy Ottomanelli, Bruno Hochberg, Jian Pan, Wen Luo, Meijuan Tian, Yaya Chu, Mitchell S. Cairo, Mitchell S. Cairo, Mitchell S. Cairo, Mitchell S. Cairo, Ander Izeta, Ander Izeta, Yanling Liao

    Published in Frontiers in Immunology (2023-09-01)
    Get full text
    Article


  8. 8

    Neurocognitive outcome in children with sickle cell disease after myeloimmunoablative conditioning and haploidentical hematopoietic stem cell transplantation: a non-randomized clin... by Suzanne Braniecki, Elliott Vichinsky, Mark C. Walters, Shalini Shenoy, Qiuhu Shi, Theodore B. Moore, Julie-An Talano, Susan K. Parsons, Allyson Flower, Anne Panarella, Sandra Fabricatore, Erin Morris, Harshini Mahanti, Jordan Milner, Robert C. McKinstry, Robert C. McKinstry, Christine N. Duncan, Carmella van de Ven, Mitchell S. Cairo, Mitchell S. Cairo, Mitchell S. Cairo, Mitchell S. Cairo, Mitchell S. Cairo

    Published in Frontiers in Neurology (2024-05-01)
    Get full text
    Article


  9. 9

    Advances in augmenting infiltration of active natural killer cells into pediatric and adult solid tumors by Shiori Eguchi, Wen Luo, Hongwen Zhu, Jeremy M. Rosenblum, Anna R. Cooper, Mitchell S. Cairo

    Published in Molecular Therapy: Oncology (2025-12-01)
    Get full text
    Article


  10. 10

    Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2+ pedia... by Patrick Soon-Shiong, Dean A. Lee, Yaya Chu, Gaurav Nayyar, Jeffrey T Safrit, Susiyan Jiang, Jeremy M. Rosenblum, Mitchell S. Cairo

    Published in Journal for ImmunoTherapy of Cancer (2021-07-01)
    Get full text
    Article


  11. 11

    Immunophenotypic, cytotoxic, proteomic and genomic characterization of human cord blood vs. peripheral blood CD56 NK cells by Evan Shereck, Nancy S Day, Aradhana Awasthi, Janet Ayello, Yaya Chu, Catherine McGuinn, Carmella van de Ven, Megan S Lim, Mitchell S Cairo

    Published in Innate Immunity (2019-07-01)
    Get full text
    Article


  12. 12

    Novel cytokine–antibody fusion protein, N-820, to enhance the functions of ex vivo expanded natural killer cells against Burkitt lymphoma by John Lee, Dean Lee, Patrick Soon-Shiong, Yaya Chu, Gaurav Nayyar, Nang Kham Su, Jeremy M Rosenblum, Jeffrey T Safrit, Matthew Barth, Mitchell S Cairo

    Published in Journal for ImmunoTherapy of Cancer (2020-10-01)
    Get full text
    Article


  13. 13

    Mitoxantrone in combination with clofarabine (MITCL) in children, adolescents and young adults with relapsed/refractory acute leukaemia: final results of a phase I/II trialResearch... by Jessica Hochberg, Javier Oesterheld, Aliza Gardenswartz, Allyson Flower, Liana Klejmont, Jackie Basso, Qiuhu Shi, Lauren Harrison, Michael J. Borowitz, Michael R. Loken, Mitchell S. Cairo

    Published in EClinicalMedicine (2025-05-01)
    Get full text
    Article


  14. 14

    CXCL10-induced chemotaxis of ex vivo-expanded natural killer cells combined with NKTR-255 enhances anti-tumor efficacy in osteosarcoma by Shiori Eguchi, Wen Luo, Hongwen Zhu, Hai M. Hoang, Changxin Xu, Gregory K. Behbehani, Kazi L. Tasneem, Janet Ayello, Mario Marcondes, Dean A. Lee, Mitchell S. Cairo

    Published in Molecular Therapy: Oncology (2025-12-01)
    Get full text
    Article


  15. 15

    Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphoma by Ronald Levy, Joshua Brody, David L Porter, Sattva S Neelapu, Koen Van Besien, Michael Werner, Michael R Bishop, Mitchell S Cairo, Sherry Adkins, Stephen M Ansell, Jonathan W Friedberg, Justin P Kline

    Published in Journal for ImmunoTherapy of Cancer (2020-10-01)
    Get full text
    Article


  16. 16

    Combinatorial immunotherapy with anti-ROR1 CAR NK cells and an IL-21 secreting oncolytic virus against neuroblastoma by Yaya Chu, Meijuan Tian, Uksha Saini, Jessica Ayala-Cuesta, Kayleigh Klose, Alyssa S. Mendelowitz, Keira Foley, Mehmet F. Ozkaynak, Wen Luo, Timothy P. Cripe, Dean A. Lee, Kevin A. Cassady, Mitchell S. Cairo

    Published in Molecular Therapy: Oncology (2025-03-01)
    Get full text
    Article


  17. 17

    Circumventing resistance within the Ewing sarcoma microenvironment by combinatorial innate immunotherapy by Dean Lee, Jeremy M Rosenblum, Mitchell S Cairo, Mario Marcondes, Timothy Cripe, Katherine Miller, Xiaokui Mo, Elaine Mardis, Wen Luo, Hai Hoang, Hongwen Zhu, Shiori Eguchi, Meijuan Tian, Yanling Liao, Janet Ayello, Mark Currier

    Published in Journal for ImmunoTherapy of Cancer (2024-09-01)
    Get full text
    Article


  18. 18

    IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas. by Xin Huang, Haein Park, Joseph Greene, James Pao, Erin Mulvey, Sophia X Zhou, Catherine M Albert, Fred Moy, Deepali Sachdev, Douglas Yee, Christoph Rader, Carl V Hamby, David M Loeb, Mitchell S Cairo, Xianzheng Zhou

    Published in PLoS ONE (2015-01-01)
    Get full text
    Article


  19. 19

    Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 in vitro and in vivo in NB xenografts by Yaya Chu, Gaurav Nayyar, Meijuan Tian, Dean A. Lee, Mehmet F. Ozkaynak, Jessica Ayala-Cuesta, Kayleigh Klose, Keira Foley, Alyssa S. Mendelowitz, Wen Luo, Yanling Liao, Janet Ayello, Gregory K. Behbehani, Stanley Riddell, Timothy P. Cripe, Mitchell S. Cairo

    Published in Molecular Therapy: Oncology (2024-06-01)
    Get full text
    Article


  20. 20

    686 Targeted immunotherapy and checkpoint blockade in children, adolescents, and young adults with lymphoma: RADICAL hodgkin cohort by Matthew Barth, Mitchell S Cairo, Megan S Lim, Lauren Harrison, Chitti Moorthy, Saro Armenian, Kayleigh Klose, Jessica C Hochberg, Jaclyn Baso, Ana C Xavier, Anthony N Audino, Rodney Miles, Samir Kahwash, Stephan D Voss, Suzanne Braniecki, Matthew Ehrhardt, Arvind Budhram, Ariel Stonberg, Stanton Goldman

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Article


Search Tools: